The claim your practice should probably stop making

Blue light filtering became one of optics' most successful upsells on the strength of claims the evidence does not support. Reviews have repeatedly failed to find meaningful benefit for eye strain, and the case for protecting the retina from screen exposure is weaker still.

This creates an awkward position for a practice that has been marketing it. The commercially convenient answer is to keep quiet. The better answer, and the more defensible one, is to change what you claim.

What people are actually experiencing

The symptoms driving demand are real. Tired, dry, aching eyes after a long day at a screen is a genuine complaint and dismissing it loses you the patient entirely.

The cause is generally not the wavelength. It is a combination of sustained near focus, a reduced blink rate while concentrating, dry environments, poor screen distance and, very often, an uncorrected or slightly outdated prescription. All of which are things a practice can genuinely help with, which is the useful part.

Why the claim is worth retiring

Beyond accuracy, there is exposure. Regulators in several jurisdictions have acted against health-protection claims for blue light filtering, and it is a well-known target rather than an obscure one.

There is a slower cost too. Patients increasingly encounter the debunking themselves, and a practice that sold them a coating on a health claim looks like a retailer that upsold them, which undermines the clinical authority the rest of the business depends on.

How to sell the lens honestly

The product does not have to disappear. Some patients genuinely prefer it, and preference is a legitimate reason to buy something. What changes is the claim attached.

  • Offer it as a comfort and appearance preference, not as protection.
  • Be straightforward that the evidence for health benefit is weak. Patients respond well to this, because almost nobody in retail says it.
  • Lead with what does help: an up-to-date prescription, working distance, breaks, blink awareness and dry eye management.
  • Where a patient has a genuine circadian or sleep concern, treat that as its own conversation rather than folding it into a lens sale.

Saying it publicly is a differentiator

Because most of the market still makes the claim, publishing the honest version stands out sharply. It signals that this practice tells patients the truth even when the truth sells a cheaper option, which is the single most valuable reputation an independent can hold.

It converts, too. Patients who read that and then book arrive already trusting the recommendation they are given, which makes the rest of the dispensing conversation considerably easier.

In short

The eye strain is real but the wavelength is mostly not the cause, so sell the coating as a preference, fix the prescription and the habits, and say so publicly.

Noian writes, schedules and publishes this kind of content for opticians and optometry practices, with every post held for your approval first.

See how it works for opticians

More for opticians and optometry practices

The most interesting thing about your practice, unsaid
Most people think a sight test measures whether they need glasses. Explaining what it actually examines is the strongest content an optical practice has, and almost nobody publishes it.
Halloween, coloured lenses, and the annual compliance trap
Zero-power coloured lenses are regulated medical devices, not accessories. Why promoting them the usual way is a problem, and how to make October work for the practice instead.
Frames photograph well, and that is the trap
Frame content is easy, visual and rewarded by every algorithm. Publishing only frames teaches your market to price-compare you with the internet. How to run both halves.